Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

User fees increase

Executive Summary

User fees for fiscal 2003 increase 70% over prior year, according to rates announced in the Federal Register Aug. 2. Prescription Drug User Fee Act fees will be $533,400 for an application requiring clinical data; $266,700 for an application not requiring clinical data or a supplement requiring clinical data; $209,900 for establishment fees; and $32,400 for product fees. FY 2002 adjusted fees were $313,320 for applications requiring clinical data and $156,660 for applications not requiring clinical data or supplements requiring clinical data....

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040282

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel